Overview Anti-infectives: The treatment of malaria with iron chelators

References

• ALONSO PL, TEUSCHER T, TANNER M: Vaccine (1994) 12, 99–101, 187–194.
   Google Scholar
• COX F: Science (1994) 264: 1528.
   Google Scholar
• RAVENTOS-SUAREZ C, POLLACK S, NAGAL RL: Amer. J. Trop. Med. Hyg. (1982) 31: 919–922.
   Google Scholar
• First demonstration that Plasmodium falciparum growing in human erythrocytes can be inhibited by desferrioxamine (1511M).
   Google Scholar
• GORDEUK V, THUMA P, BRIIIENHAM G, McLAREN C, PARRY D, BACKENSTOSE A, BIEMI3A G, MSISKA R, HOL-MES L, McKINLYE E, VARGAS L, GILKESON R, POLTERA AA: Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. New. Eng. J. Med. (1992) 237: 1473–1477.
   Google Scholar
• First demonstration in man that iron chelation therapy may hasten the clearance of parasitemia and enhance recovery from deep coma in cerebral malaria.
   Google Scholar
• PASVOL G. CLOUGH B, CARLSSON J: Malaria and the red cell membrane. Blood Reviews (1992) 6: 183–192.
   PubMedGoogle Scholar
• CABANTCHIK ZI: Altered membrane transport of malaria-infected erythrocytes: a possible pharmacological target. Blood (1989) 74: 1464–1471.
   PubMedGoogle Scholar
• Review of the discrete alteration that occurs in the permeability of the RBC membrane as a result of intracellular parasite growth. The host cell becomes an obvious target for differential drug action; new absorption pathway may be affected by drugs otherwise impermeant to uninfected cells.
   Google Scholar
• GOLDBERG DE, SLATER AFG, CERAMI A, HENDERSON GB. Proc. Natl. Acad, Sci. USA (1990) 87: 2931–2935.
   PubMedGoogle Scholar
• SLATER AF, SWIGGAI1D WJ, ORTON BR, FLITTER WD, GOLDBERG DE, CERAMI A, HENDERSON GB: An iron-car-boxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. USA (1991) 88: 325–329.
   PubMed Web of Science ®Google Scholar
• ALBERT A, REES CW, TOMLINSON AJH: Why are metal-binding substances anti-bacterial? Recueil. (1956) 75: 819–824.
   Google Scholar
• First of a series of papers published by Albert et al. devoted to the comprehension of the cytotoxic properties of iron(Ill) chelators.
   Google Scholar
• SCHEIBEL LW, ADLER A: DI 8-hydroxyquinolines (ox-ines) substituted in position 5 and 7 and oxfires an-nelated in position 5, 6 by an aromatic ring. Mol. Pharmacol. (1982) 22: 140–144.
   PubMed Web of Science ®Google Scholar
• SCHEIBEL LW, ADLER A: Antimalarial activity of selected aromatic chelators. Mole. Pharmacol (1980) 18: 320–325..
   PubMed Web of Science ®Google Scholar
• SCHEIBEL LW: In vitro inhibition of the human malaria parasite by selected lipophilic chelators IN: The Red Cell. (1984) 6th Ann Arbar Conference A.R. Liss, New York, pp377–389
   Google Scholar
• \WHITEHEAD S, PETO TEA: Stage-dependent effect of desferrioxamine on growth ofPlasmodiumfalciparum in vitro. Blood (1990) 76: 1250–1255.
   Google Scholar
• Using synchronised in vitro cultures of P. falciparum, growth inhibition by desferrioxamine was detected within a single parasite cycle. Profound growth inhibition with no subsequent recovery occured only when pigmented trophozoites and early schizonts were exposed to desferrioxamine.
   Google Scholar
• GANESHAGURU K, HOFFBRAND AV, GRADY RW, CERAMIA: Effect of iron chelating agents on DNA synthesis in human cells. Biochem. Pharmacol. (1980) 29: 1275–1279.
   PubMed Web of Science ®Google Scholar
• CORY JG, LASATER L, SATO A: Effect of iron chelating agents on inhibitors of ribonudeotide reductase. Bio-chem. Pharmacol. (1981) 30: 979–984.
   PubMed Web of Science ®Google Scholar
• FRITSCH G, SAWATZKI G, TREUMER J, JUNG A, SPIRA DT: Plamodium fakiparum: Inhibition in vitro with lac-toferrin, desferrithiocin and desferricrocin. Exp. Parasi-tol. (1987) 63: 1.
   PubMed Web of Science ®Google Scholar
• HEPPNER DG, HALLAWAY PE, KONTOGHIORGHES GJ, EATON JW: Antimalarial properties of orally active iron chalators. Blood (1988) 72: 358–361.
   PubMed Web of Science ®Google Scholar
• HERSHKO C, GORDEUK VR, THUMA PE, THEANACHO EN, SPIRA, DT, HIDER RC, PETO TEA, BRII1hNHAM GM: Theantimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria. J. Inorg. Biochem. (1992) 47: 267–277.
   PubMed Web of Science ®Google Scholar
• YINNAN AM, THEANACHO EN, GRADY RW, SPIRA DT, HERSHKO C: Antimalarial effect of HBED and other phenolic and catecholic iron chelators. Blood (1989) 74: 2166–2171.
   PubMedGoogle Scholar
• IHEANACHO EN, SAREL S. SAMUNI A, AVRAMOVICI-GRISARU S, SPIRA DT: Growth inhibition of Plasmodium falciparum involving carbon centred iron-chelate radical (L; X-)-Fe(m) based on pyridoxal-betaine. A novel type of antimalarial active against chloroquine-resis-tant parasites. Free Rad. Res. Comm. (1991) 15: 1–10
   Google Scholar
• BASCO LK, MITAKU S, SKALTSOUNIS AL, RAV-ELOMANANTSOA N, TILLEQUIN F, KOCH M, LEBRAS J: In vitro activities of furoquinoline and acridone alkaloids against Plasmodium fakiparum. Antimicrob. Agent Chemother. (1994) 38: 1169–1171.
   PubMed Web of Science ®Google Scholar
• SHANZER A, LIBMAN 3, LYTTON SD, GLICKSTEIN H, CABANTCHIK ZI: Reversed siderophores act as anti-malarial agents. Proc. Natl, Acad. Sci. USA (1991) 88: 6585–6589.
   PubMed Web of Science ®Google Scholar
• LYTTON SD, MESTER B, DAYAN I, GLICKSTEIN H, LIBMAN J, SH_ANZER A, CABANTCHIK ZI: Mode of action of Iron(RI) chelators as antimalarials: 1. Membrane per-meation properties and cytotoxic activity. Blood (1993) 81: 214–221.
   Google Scholar
• YANG YZ, RANZ A, PAN HZ, ZHANG ZN, UN XB, MESHNICK SR: Dapluietin: a novel antimalarial agent with in vitro and in vivo activity. Amer. J. Trop. Med. Hyg. (1992) 46: 15–20.
   PubMedGoogle Scholar
• VENNERSTROM JL, EATON JW: Oxidants, oxidant drugs and malaria. J. Med. Chem. (1988) 31: 1269–1277.
   PubMed Web of Science ®Google Scholar
• FIESER LF, RICHARDSON AP: Naphthoquinone anti-malarials . J. Amer. Chem. Soc (1948) 70: 315–3176. This reference includes an important series of eleven papers, which together, report Fiesers pioneering work with naphthoquinones during the Second World War.
   Google Scholar
• BOEHM P, COOPER K, HUDSON AT: In vitro activity of 2-alkyl-3-hydroxy-1,4-naphthoquinones against Mei,-eria parva. J. Med. Chem. (1981) 24: 295–299.
   PubMed Web of Science ®Google Scholar
• PETO TEA, THOMPSON JL: A reappraisal of the effects of Iron and desferrioxamine on the growth of Plasmo-dium falciparum in vitro: the unimportance of serum Iron. Brit. J. Haematot (1986) 63: 273–280.
   PubMedGoogle Scholar
• HERSHKO C, PETO TEA: Desferrioxamine inhibition of malaria is independent of host iron status. J. Exper. Med (1988) 168: 375.
   PubMedGoogle Scholar
• PORTER JB, COOPER C, CAMMACK R (Personal Communication).
   Google Scholar
• VAN ZYL RL, HAVLIK I, HEMPLEMANN E, MacPHAIL AP, McNAMARO L: Malaria pigment and excellular iron. Possible target for iron chelating agents. Biochem. Phar-macol. (1993) 45: 1431–1436.
   PubMed Web of Science ®Google Scholar
• MESHNICK SR, YANG YZ, LIMA V, KUYPERS F, KAMCHON-WONGPAISAN S, YUTHOVONG Y: Iron-dependent free radical generation from the antimalarial agent arterais-hrin (Quinghasosu). Antimicrob. Agents and Cbemother. (1993) 37: 1108–1114.
   PubMed Web of Science ®Google Scholar
• PORTER JB, HUEHNS ER, HIDER RC: The development of iron chelating drugs. Bailliere's Clinical Haematology (1989) 2: 257–292.
   PubMedGoogle Scholar
• This review outlines the critical properties required of an ideal orally active iron chelator. A wide range of chemically different chelators are compared.
   Google Scholar
• FRY M, PUDNEY M: Site of action of the antimalarial hydroxynaphthoquthone2ttrans-4-(4'-chlorophenyl) cycloherry11-3-hydroxy-1,4-naphthoquinone (566C80). Biochem. Pharmacol. (1992) 43: 1545–1553.
   PubMed Web of Science ®Google Scholar
• NORDLUND P. SJOBERG BM, EKLUND H: Three-dimensional structure of the free radical protein of ribonu-cleotide reductase. Nature (1990) 345: 593–598.
   PubMed Web of Science ®Google Scholar
• The structure of ribonucleotide reductase, a likely target for iron chelators, is described to 2.2 Á resolution. Although the enzyme was isolated from Escherichia colt it is homologous with the mammalian enzyme family.
   Google Scholar
• HOYES KP, HIDER RC, PORTER JB: Cell cycle synchronisation and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines. Cancer Research (1992) 52: 4591–4599.
   PubMed Web of Science ®Google Scholar
• Hydroxypyridones and desferrioxamine are demonstrated to arrest the cell cycle of K562 and Daudi cells, in a dose-dependent manner. A block at the G1-S border occurs after 24 hat concentrations above 30 1.0/1 iron binding capacity. This is associated with reduced ribonucleotide reductase activity and concomitant cessation of DNA synthesis and growth.
   Google Scholar
• RUBIN H, SALEM JS, LI LS, YANG FD, MAMA S, WANG ZM, FISHER A, HAMANN CS, COOPERMAN BS: Cloning, se-quence determination and regulation of the ribonu-cleotide reductase subunits from Plasmodium fakiparum: A target for antimalarial therapy. Proc. Natl. Acad. Sci. USA (1993) 90: 9280–9284.
   PubMed Web of Science ®Google Scholar
• Reports the full-length DNA sequence corresponding to both subunits of P. falciparum ribonucleotide reductase. A striking dif-ference exists between the C-terminae of the small subunits of the human and falciparum enzyme. This difference may offer a means of designing selective therapeutic agents.
   Google Scholar
• PORTER JB: Oral iron chelators; prospects for futuredevelopment. Eur. J. Haematol. (1989) 43: 271–285.
   PubMed Web of Science ®Google Scholar
• SCOTT MD, RANZ A, KUYPERS FA, LUBIN BH, MESHNICKSR: Parasite uptake of desferrioxamine: a prerequisite for antimalarial activity. Brit. J. Haematol. (1990) 75: 598–602.
   PubMed Web of Science ®Google Scholar
• POLLACK S, ROSSAN RN, DAVIDSON DE, ESCAJADILLO A:Desferrioxamine suppresses Plasmodium falciparum In Aotus monkeys. Proc. Soc. Exp. Biol. Med. (1987) 184: 162–164.
   PubMed Web of Science ®Google Scholar
• GORDEUK VR, THUMA PE, BRTTTENHAM GM, ZULU S, SIMWANZA G, MHANG, A, FLESCH G, PARRY D: Iron chelation with desferrioxamine 13 in adults with asymp-tomatic Plasmodium falciparum parasitemia. Blood (1992) 79: 308–312.
   PubMed Web of Science ®Google Scholar
• The first clinical demonstration of antimalarial activity of desferriox-amine.
   Google Scholar
• BUNNAG D, POLTERA AA, VIRAVAN C, LOOAREESUWAN S, HARINASUTA KT, SCHINDLERY C: Plasmodicidal effect of desferrioxamine-l3 in human vivax or falciparum malaria from Thailand. Ada Trop. Basel (1992) 52: 59–67.
   PubMed Web of Science ®Google Scholar
• HIDER RC, PORTER JB, SINGH S: In: The design of therapeu-tically useful iron chelators in the development of iron chela-tors for clinical use. (1994). BERGERON RJ, BRIIIENHAM GM, (Eds.) CRC Press, An Arbor. pp353–371.
   Google Scholar
• PORTER JB, MORGAN J, HOYES KP, BURKE LC, HUEFINS ER, HIDER RC: Relative and efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice. Blood (1990) 76: 2389–2396.
   PubMed Web of Science ®Google Scholar
• DOBBIN PS, HIDER RC, HALL AD, TAYLOR PD, SARPONGP, PORTER JB, XIAO G, VAN DER HELM D: Synthesis, physicochemical properties and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(11-2)pyridinones: Orally active iron chelators with clinical potential. j. Med. Chem. (1993) 36: 2448–2458.
   PubMed Web of Science ®Google Scholar
• PORTER JB, GYPARAKI M, BURKE LC, HUEHNS ER, SAR-PONG P, SAEZ V, HIDER RC: Iron mobilization from hapatocyte monolayer cultures by chelators: The im-portance of membrane permeability and the iron-bind-ing constant. Blood (1988) 72: 1497–1503.
   PubMed Web of Science ®Google Scholar
• KANAANI J, GINSBURG H: Transport of lactate in Plas-modium falciparum-infected human erythrocytes. J. Celt. Phystol (1991) 149: 469–476.
   PubMedGoogle Scholar
• KANAANI J, GINSBURG H: Effect of cinnamic acid deriva-tives on in vitro growth ofPlasmodiumfalciparum and on the permeability of the membrane of malaria-in-fected erythrocytes. Antirnicrob. Agents aemother.(1992) 36: 1102–1108 .
   PubMedGoogle Scholar
• SINGH S: Therapeutically useful iron chelators. Chem. &Ind. (1994) 452–455.
   Google Scholar